ONJCRI Monepantel Signalling Pathway Update
200929_PAA_ONJCRI Update
LUMC COVID-19 Clarification Statement
200928_Clarification Statement on LUMC and COVID-19 work
LUMC and PAA Agreement for COVID-19 Work
200924_LUMC-PAA-Agreement
200921_PharmAust Awarded FightMND Grant for Phase I Trial
200921_PAA_FightMND
14 September, Shareholder Update
200914_Shareholder Update
Elanco not to Exercise Agreed Option
200909_Elanco not to Exercise Agreed Option
Monepantel Anti-Covid-19 Activity Confirmed
200909_Monepantel Anti-Covid-19 Activity Confirmed
August 31, Top 20 Shareholders
200831_Top_20_Holders
Epichem waste-to-fuels technology partnership
200901_Epichem waste to fuels technology partnership
Appendix 4E & Preliminary Final Report
200831_Appendix 4E & Preliminary Final Report